The 4 analysts offering 12-month price forecasts for InflaRx NV have a median target of 5.30, with a high estimate of 8.14 and a low estimate of 1.93. The median estimate represents a +104.74% increase from the last price of 2.59.
The current consensus among 5 polled investment analysts is to Buy stock in InflaRx NV. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.33
Reporting Date Nov 04
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.